Xconomy Forum: Innovation at Biotech’s Epicenter

The San Francisco Bay Area is the birthplace of modern biotech, and it runs neck and neck with Cambridge, MA, as the world’s pre-eminent life sciences hub. Much of the Bay Area’s activity has taken place outside San Francisco itself, but now the city is becoming part of the fabric as the Mission Bay neighborhood transforms into the next great urban biotech core. On December 17, we’re gathering to discuss how the Bay Area, from Mission Bay to Berkeley to Silicon Valley, will provide unique biotech leadership in the 21st century. It’s the home of biomedical history and hallowed institutions, and it’s also teeming with anti-establishment ideas. Its entrepreneurs are turning cutting-edge science into companies to treat and cure diseases, and they’re also turning to new digital technologies to remake healthcare (and perhaps prevent disease in the first place). Join us to shake things up with an afternoon of fast-paced discussion, debate, and science in Mission Bay, the Bay Area’s new biotech epicenter.

Host Welcome:

Regis Kelly
- Director, QB3

Confirmed Speakers:

Sam Hawgood
- Chancellor, University of California, San Francisco
C. Randal Mills
- President and CEO, California Institute for Regenerative Medicine
Mark Goldsmith
- Partner, Third Rock Ventures
Gini Deshpande
- CEO, NuMedii
Lindy Fishburne
- Executive Director, Breakout Labs; SVP for Investments, Thiel Foundation
Dongliang Ge
- Director of Bioinformatics, Gilead Sciences
Arvind Gupta
- Investment Partner, SOSventures; Co-founder, IndieBio Accelerator
Chris Haskell
- Head, U.S. Science Hub, Bayer HealthCare
Robert C. Jones
- EVP, Research and Development, Fluidigm
Ted Love
- CEO, Global Blood Therapeutics
Stephanie Marrus
- Director, Entrepreneurship Center, University of California, San Francisco
Rick Morrison
- CEO, Comprehend Systems
Jack Newman
- Co-founder and CSO, Amyris
David Shaywitz
- CMO, DNAnexus